Diabetes impacts worse prognosis in post-MI patients treated with PCI and antithrombotics

Diabetes impacts worse prognosis in post-MI patients treated with PCI and antithrombotics

2020.09.28

In an effort to evaluate the prognostic significance of diabetes mellitus (DM) in patients with high-risk acute myocardial infarction (MI) receiving primary percutaneous coronary intervention (pPCI)...

PD and PK study of ticagrelor loading dose in Chinese ACS patients

PD and PK study of ticagrelor loading dose in Chinese ACS patients

2020.09.25

The pharmacodynamics (PD) and pharmacokinetics (PK) of ticagrelor loading dose (LD) in Chinese patients with acute coronary syndrome (ACS) without opioid administration have not been investigated....

Secondary prevention combination therapy with beta-blocker and statin reduced MACE in ACS patients

Secondary prevention combination therapy with beta-blocker and statin reduced MACE in ACS patients

2020.09.21

A combination therapy of beta-blocker and statin more effectively lowered the risk of developing major adverse cardiovascular event (MACE) in patients with acute coronary syndrome (ACS), compared...

Implications of risk stratification for cholesterol management in ACS secondary prevention

Implications of risk stratification for cholesterol management in ACS secondary prevention

2020.09.18

In the 2018 American College of Cardiology/American Heart Association cholesterol guidelines for secondary prevention, patients are classified as ‘very high risk’ (VHR), either because of...

Ticagrelor showed benefits in post-MI stroke prevention among East Asian patients: A nationwide cohort study

Ticagrelor showed benefits in post-MI stroke prevention among East Asian patients: A nationwide cohort study

2020.09.14

Ticagrelor improves clinical outcomes in patients with acute myocardial infarction (AMI). A study was conducted to compare the efficacy and safety of ticagrelor versus clopidogrel in East Asian...

Ticagrelor showed greater antiplatelet efficacy than clopidogrel in diabetic patients post-PCI

Ticagrelor showed greater antiplatelet efficacy than clopidogrel in diabetic patients post-PCI

2020.09.07

Clopidogrel is currently the only P2Y12 inhibitor with class I recommendation in patients after percutaneous coronary intervention (PCI) for chronic coronary syndromes (CCS). However, it is noted...

Mid-range ejection fraction in STEMI patients linked to higher adverse outcomes

Mid-range ejection fraction in STEMI patients linked to higher adverse outcomes

2020.08.31

Evidence is sparse on the impact of mid-range ejection fraction (mrEF) on clinical outcomes including ventricular arrhythmias and in ST-segment-elevation myocardial infarction (STEMI). Therefore, a...

Effects of the Beijing tobacco control policy on AMI and stroke hospital admissions

Effects of the Beijing tobacco control policy on AMI and stroke hospital admissions

2020.08.24

The MPOWER tobacco control policy package has been implemented in Beijing since June 2015. In an interrupted time series study, researchers sought to assess the impact of the policy on hospital...

Abnormal glucose tolerance linked to increased MACE risk among patients with MI

Abnormal glucose tolerance linked to increased MACE risk among patients with MI

2020.08.17

Patients with acute myocardial infarction (MI) have a high prevalence of newly discovered abnormal glucose tolerance (AGT), according to results from a meta-analysis. Data were extracted from...

Impact of ticagrelor on coronary artery function in East Asians

Impact of ticagrelor on coronary artery function in East Asians

2020.08.10

In a study, researchers hypothesized that ticagrelor might improve coronary microvascular function, and investigated the antiplatelet effect of low-dose ticagrelor in East Asian patients.A total of...